Related Experiment Video
Updated: Jul 11, 2025

Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
Developing a nurse-led salbutamol weaning pathway for children and young people with asthma or viral-induced wheeze
1general paediatrics, Alder Hey Children's NHS Foundation Trust, Liverpool, England.
Insights
Nurses reported increased confidence in managing salbutamol weaning for children with wheeze after training. A new nurse-led pathway aims to improve patient care and confidence in nursing assessments for asthma exacerbations.
Area of Science:
- Pediatric Pulmonology
- Nursing Education
- Quality Improvement in Healthcare
Background:
- Acute asthma exacerbations and viral-induced wheeze are frequent admissions in pediatric wards.
- Salbutamol (inhaled beta-2 agonist) is the primary treatment, requiring careful weaning before discharge.
- Informal weaning practices and staffing challenges necessitated a structured approach.
Purpose of the Study:
- To develop and evaluate a nurse-led salbutamol weaning pathway.
- To assess nurses' perceptions of a new training and competency package.
- To improve the quality of care for pediatric patients with wheeze.
Main Methods:
- A quality improvement project implemented a nurse-led salbutamol weaning pathway.
- Twelve nurses completed a specialized training, education, and competency program.
- A post-training questionnaire assessed nurses' perceptions of the pathway and training.
Main Results:
- All nurses reported enhanced confidence in assessing salbutamol requirements.
- Respondents believed the pathway would improve patient care and family confidence in nursing assessments.
- Nurses perceived the training positively, enhancing their ability to manage wheeze exacerbations.
Conclusions:
- The nurse-led salbutamol weaning pathway and training enhance nursing confidence and perceived patient care quality.
- This initiative addresses challenges in managing pediatric wheeze exacerbations.
- Time constraints were identified as a potential barrier to full pathway implementation.
Abstract:
Acute asthma exacerbations and viral-induced wheeze are common presenting complaints on one general paediatric ward in a tertiary children's hospital in England. An inhaled beta 2 agonist, such as salbutamol, is the first-line treatment for these children and young people and they have frequent clinician reviews for salbutamol weaning before discharge. However, the informal salbutamol weaning practices used by nurses, as well as challenges in the recruitment and retention of paediatric trainee doctors, led to the development of a nurse-led salbutamol weaning pathway as a quality improvement project. Twelve nurses completed the associated nurse-led salbutamol weaning training, education and competency package and subsequently completed a questionnaire exploring their perceptions of the effect of the training package and pathway. After the training, all respondents reported feeling more confident in assessing the salbutamol requirements of children with wheeze. All of the respondents also felt that the introduction of the pathway and training would improve patient care and the confidence of children and young people, parents and carers in nurses' ability to assess children's salbutamol requirements. Time constraints were identified as a potential barrier to implementation of the pathway.
Related Concept Videos
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Inhaled Medications
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

